FTMAX | GSGPX | FTMAX / GSGPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 7 years | - |
Gain YTD | 0.826 | 2.608 | 32% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 751M | 4.76B | 16% |
Annual Yield % from dividends | 5.76 | 2.62 | 220% |
Returns for 1 year | 6.35 | 9.61 | 66% |
Returns for 3 years | 10.86 | 15.28 | 71% |
Returns for 5 years | 22.20 | 14.01 | 158% |
Returns for 10 years | 24.26 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 70.44 | 0.82 | +1.18% |
Janus Henderson Global Life Sciences A | |||
NCEGX | 21.60 | N/A | N/A |
The North Country Large Cap Equity Fund | |||
RMQHX | 545.45 | N/A | N/A |
Rydex Monthly Rbl NASDAQ-100® 2x Strt H | |||
EEMDX | 7.93 | N/A | N/A |
MFS Emerging Markets Equity Research R1 | |||
GIIZX | 12.05 | N/A | N/A |
GuideStone Funds Intl Eq Idx Investor |